Accelrys Wraps Up Financial Restatement, Posts Decrease in Q4 Revenues, Lower Loss | GenomeWeb

NEW YORK, May 24 (GenomeWeb News) - Accelrys has completed a restatement of its financial results for the past five years and has filed its quarterly report for the three months ended Dec. 31, 2005, as well as its annual report for its fiscal year ended March 31, 2006.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.